Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Visningar
• 07/30/23
0
0
Bädda in
administrator
Prenumeranter
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna